Doctor profile · Federal record

Dr. Herold Osborne, P.A-C

Medical Physician Assistant (CMS: Physician Assistant) · Physician Assistant · Longview, TX

  • NPI 1710999727
  • Accepts Medicare
  • MIPS 88.5 / 100 · 2023
  • 27 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
3535 N Fourth St Ste 400
Longview, TX 756050038
(903) 757-3881
fax (903) 757-5948

Credentials & registration

NPPES · NUCC
NPI registered
August 2006 — 20 yrs on file
Profile last updated
March 3, 2021
Year of graduation
1999 — 27 yrs since
Specialty taxonomy
363AM0700X — NUCC code
State license (1)
Texas #PA01750

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1710999727. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
2,032
Distinct HCPCS
10
Medicare allowed
$112,106
HCPCS Description Services Patients Avg allowed
99213 Established patient office or other outpatient visit, 20-29 minutes 500 464 $74
17003 Destruction of precancer skin growth, 2-14 growths 463 163 $5
17000 Destruction of precancer skin growth, 1 growth 296 281 $45
11102 Biopsy of related skin growth, first growth 158 154 $78
99203 New patient office or other outpatient visit, 30-44 minutes 136 136 $92
17110 Destruction of skin growth, 1-14 growths 135 128 $91
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 95 19 $1
99214 Established patient office or other outpatient visit, 30-39 minutes 93 90 $104
99204 New patient office or other outpatient visit, 45-59 minutes 48 48 $137
11103 Biopsy of related skin growth, each additional growth 40 30 $41

In context: peer comparison

Among 3 peers in this city , average services per provider: 98. This provider delivers 21× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,313
Transactions
120
Manufacturers
14
Payer (manufacturer) Industry Txns Amount
Janssen Biotech, Inc. 17 $446.39
ABBVIE INC. 31 $443.21
Regeneron Healthcare Solutions, Inc. 9 $329.50
GENZYME CORPORATION 16 $271.07
Lilly USA, LLC 10 $183.71
E.R. Squibb & Sons, L.L.C. 13 $167.32
Ortho Dermatologics, a division of Bausch Health US, LLC 9 $133.99
Incyte Corporation 4 $88.28
Novartis Pharmaceuticals Corporation 3 $62.63
LEO Pharma Inc. 2 $54.42
STRATA Skin Sciences, Inc. 1 $53.54
Dermavant Sciences, Inc. 2 $31.26
SUN PHARMACEUTICAL INDUSTRIES INC. 2 $28.97
Arcutis Biotherapeutics, Inc. 1 $19.12

By nature of payment

Food and Beverage
$2,129
Education
$184

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
483
Patients
260
Total drug cost
$383,555
Drug Type Claims Patients Total cost
Minocycline Hcl Generic 81 22 $1,861
Triamcinolone Acetonide Generic 55 48 $652
Mometasone Furoate Generic 46 40 $1,330
Ketoconazole Generic 43 28 $1,048
Doxycycline Hyclate Generic 41 27 $1,430
Doxycycline Monohydrate Generic 32 12 $989
Betamethasone Dipropionate Generic 31 23 $1,978
Methotrexate (Methotrexate Sodium) Brand 30 0 $714
Clobetasol Propionate Generic 28 20 $1,520
Hydrocortisone Generic 21 16 $185

Frequently asked questions

Auto-generated from federal data
What is Dr. Herold Osborne's medical specialty?
Dr. Herold Osborne practices Medical Physician Assistant in Longview, TX.
Where does Dr. Herold Osborne practice?
Dr. Herold Osborne practices at 3535 N Fourth St Ste 400, Longview, TX 756050038. Office phone: 9037573881.
What is Dr. Herold Osborne's NPI?
Dr. Herold Osborne's National Provider Identifier (NPI) is 1710999727, issued by NPPES.
Does Dr. Herold Osborne accept Medicare assignment?
Yes. Dr. Herold Osborne accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Herold Osborne commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.